Targeting acetylcholinesterase and butyrylcholinesterase in dementia

RM Lane, SG Potkin, A Enz - International Journal of …, 2006 - academic.oup.com
Abstract The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying
the cognitive and neuropsychiatric dysfunctions in patients with AD. Inhibition of brain …

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

R Schliebs, T Arendt - Journal of neural transmission, 2006 - Springer
Acetylcholine is widely distributed in the nervous system and has been implicated to play a
critical role in cerebral cortical development, cortical activity, controlling cerebral blood flow …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design

G Johnson, SW Moore - Current pharmaceutical design, 2006 - ingentaconnect.com
The peripheral anionic site of acetylcholinesterase lies at the entrance to the active site
gorge. It is composed of five residues (Tyr 70, Asp 72, Tyr 121, Trp 279 and Tyr 334; …

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors

A Castro, A Martinez - Current pharmaceutical design, 2006 - ingentaconnect.com
Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of
the current difficulties is related to the lack of solid evidence about the ultimate factors that …

Inhibition of two different cholinesterases by tacrine

M Ahmed, JBT Rocha, M Corrêa, CM Mazzanti… - Chemico-biological …, 2006 - Elsevier
Kinetic parameters of the effect of tacrine as a cholinesterase inhibitor have been studied in
two different sources: snake venom (Bungarus sindanus) acetylcholinesterase (AChE) and …

Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents

G Petroianu, K Arafat, BC Sasse… - Die Pharmazie-An …, 2006 - ingentaconnect.com
Novel highly affine histamine H3 receptor ligands with additional inhibitory effects on the
main histamine metabolizing enzyme in the brain, N-methyltransferase, chemically show …

[PDF][PDF] Anticolinesterásicos en el tratamiento de la enfermedad de Alzheimer

L Gandía, RM Álvarez, JM Hernández-Guijo… - Rev …, 2006 - researchgate.net
Introduction. Among the numerous pathophysiological theories that attempt to explain the
development of Alzheimer's disease (AD) there are two facts that stand out above the rest …

Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine

MA Kamal, P Klein, Q Yu, D Tweedie… - Journal of …, 2006 - content.iospress.com
An explosion in the incidence of neurodegenerative diseases, particularly Alzheimer's
disease (AD), is predicted in coming decades. Hence, the need to devise and assess new …

Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine

MA Kamal, AA Al-Jafari, QS Yu, NH Greig - Biochimica et Biophysica Acta …, 2006 - Elsevier
Accompanying the gradual rise in the average age of the population of most industrialized
countries is a regrettable progressive rise in the number of individuals afflicted with age …